These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31187126)

  • 1. Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.
    Somsouk M; Rachocki C; Mannalithara A; Garcia D; Laleau V; Grimes B; Issaka RB; Chen E; Vittinghoff E; Shapiro JA; Ladabaum U
    J Natl Cancer Inst; 2020 Mar; 112(3):305-313. PubMed ID: 31187126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
    Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
    Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cost-effectiveness of mailed fecal immunochemical testing (FIT)-based interventions for increasing colorectal cancer screening in the Medicaid population.
    Wheeler SB; O'Leary MC; Rhode J; Yang JY; Drechsel R; Plescia M; Reuland DS; Brenner AT
    Cancer; 2020 Sep; 126(18):4197-4208. PubMed ID: 32686116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outreach for Annual Colorectal Cancer Screening: A Budget Impact Analysis for Community Health Centers.
    Liss DT; French DD; Buchanan DR; Brown T; Magner BG; Kollar S; Baker DW
    Am J Prev Med; 2016 Feb; 50(2):e54-61. PubMed ID: 26362405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
    Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Notification Calls Prior to Mailed Fecal Immunochemical Test in Previously Screened Patients: a Randomized Controlled Trial.
    Lee B; Patel S; Rachocki C; Issaka R; Vittinghoff E; Shapiro JA; Ladabaum U; Somsouk M
    J Gen Intern Med; 2020 Oct; 35(10):2858-2864. PubMed ID: 32748345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Cost of an Enhanced Mailed Fecal Test Outreach Colorectal Cancer Screening Program: Findings from the PROMPT Stepped-Wedge Trial.
    Coronado GD; Nyongesa DB; Escaron AL; Petrik AF; Thompson JH; Smith D; Davis MM; Schneider JL; Rivelli JS; Laguna T; Leo MC
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1608-1616. PubMed ID: 37566431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
    Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial.
    Goldman SN; Liss DT; Brown T; Lee JY; Buchanan DR; Balsley K; Cesan A; Weil J; Garrity BH; Baker DW
    J Gen Intern Med; 2015 Aug; 30(8):1178-84. PubMed ID: 25814264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
    Mehta SJ; Induru V; Santos D; Reitz C; McAuliffe T; Orellana C; Volpp KG; Asch DA; Doubeni CA
    JAMA Netw Open; 2019 Aug; 2(8):e1910305. PubMed ID: 31469393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice.
    Green BB; Coronado GD; Schwartz M; Coury J; Baldwin LM
    Implement Sci; 2019 May; 14(1):53. PubMed ID: 31142348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis.
    Jager M; Demb J; Asghar A; Selby K; Mello EM; Heskett KM; Lieberman AJ; Geng Z; Bharti B; Singh S; Gupta S
    Dig Dis Sci; 2019 Sep; 64(9):2489-2496. PubMed ID: 30915656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
    Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
    Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.